Clinical Trials Directory

Trials / Completed

CompletedNCT01583595

Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease

Determining the Relationships Between Self-efficacy for Walking Ability, Gate Speed and Physical Activity in Patients With Chronic Lung Disease

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate). Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.

Conditions

Timeline

Start date
2011-12-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2012-04-24
Last updated
2013-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01583595. Inclusion in this directory is not an endorsement.